bioAffinity Technologies, Inc. (BIAF)
(Delayed Data from NSDQ)
$0.30 USD
-0.01 (-1.94%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $0.30 0.00 (0.67%) 4:40 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Market Cap
As of the previous market close, bioAffinity Technologies, Inc. has a market cap of $8.65M, which represents its share price of $0.30 multiplied by its outstanding shares number of 28.46M. As a small-cap company, BIAF's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
BIAF 0.30 -0.01(-1.94%)
Will BIAF be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for BIAF based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BIAF
The Zacks Analyst Blog Highlights Meta Platforms, ServiceNow, Booking, Vaso and bioAffinity Technologies
Top Research Reports for Meta Platforms, ServiceNow & Booking
BIAF: What are Zacks experts saying now?
Zacks Private Portfolio Services
BIAF Stock Rises Post Q1 Earnings Despite Revenue Decline
The Zacks Analyst Blog Highlights Alphabet, Berkshire Hathaway, Visa and bioAffinity Technologies
Top Stock Reports for Alphabet, Berkshire Hathaway & Visa
Other News for BIAF
BIAF Gains Canadian Patent for Innovative Lung Disease Detection Method | BIAF Stock News
BioAffinity Technologies awarded new Canadian patent for CyPath Lung